Is semaglutide the same as Ozempic and Wegovy?

Yes — those are brand names for semaglutide at different doses and indications. Ozempic and Rybelsus are for type 2 diabetes; Wegovy is dosed for weight management.

Does the weight come back if you stop?

Trials show much of the lost weight tends to return after stopping, because the appetite effects depend on continued dosing. It is studied as an ongoing therapy, not a short course.

← Catalog

Semaglutide

Established

Also known as Ozempic, Wegovy, Rybelsus

GLP-1 receptor agonist

The molecule that rewrote what weight loss looks like.

References: 4
Human-grade claims: 2 of 2
Evidence floor: Established
Status: Approved

A long-acting GLP-1 analog that turns down appetite and slows gastric emptying. It is FDA-approved for type 2 diabetes and chronic weight management, and it carries some of the largest randomized outcome data of any peptide in this catalog.

metabolicGLP-1approved

How it works

Semaglutide mimics GLP-1, a gut hormone released after eating. It boosts glucose-dependent insulin release, slows how fast the stomach empties, and acts on appetite centers in the hypothalamus — so you feel full sooner and stay full longer. A fatty-acid chain lets it bind albumin in the blood, stretching its action to about a week per dose.

Sequence: GLP-1(7-37) backbone with Aib8, Arg34, and a C18 di-acid on Lys26A modified analog of human GLP-1, not a natural sequence: Aib at position 8 resists DPP-4, and the acylation on Lys26 binds albumin for a ~1-week half-life. Not cleanly representable as plain one-letter code.

What it's studied for

Produced ~14.9% mean body-weight loss vs ~2.4% on placebo over 68 weeks in adults with obesity (STEP 1).
Established
[1] Wilding et al., 2021 (NEJM, STEP 1)
Cut major adverse cardiovascular events by ~20% in patients with cardiovascular disease and obesity but not diabetes (SELECT).
Established
[2] Lincoff et al., 2023 (NEJM, SELECT)

Safety & limitations

Most common effects are gastrointestinal — nausea, vomiting, diarrhea — usually easing over time. The label carries a boxed warning for thyroid C-cell tumors (seen in rodents) and contraindicates use with a personal or family history of medullary thyroid carcinoma or MEN 2.

[4] FDA label — Wegovy (accessdata)

Regulatory & legal status

Approved

FDA-approved: Ozempic (type 2 diabetes, 2017), Rybelsus (oral, type 2 diabetes, 2019), and Wegovy (chronic weight management, 2021; cardiovascular risk reduction added 2024).

[3] FDA label — Ozempic (accessdata)

Frequently asked

Is semaglutide the same as Ozempic and Wegovy?: Yes — those are brand names for semaglutide at different doses and indications. Ozempic and Rybelsus are for type 2 diabetes; Wegovy is dosed for weight management.
Does the weight come back if you stop?: Trials show much of the lost weight tends to return after stopping, because the appetite effects depend on continued dosing. It is studied as an ongoing therapy, not a short course.

References

Written by Twenty Residues editorial. Reviewed by Pending named medical review.

Last updated September 19, 2026.

Update history

2026-09-19 — Sourced review — every claim checked against primary literature; sequence, regulatory status, safety, and FAQs added.